Why the study?
The diagnosis and management of prosthetic aortic valve thrombosis is challenging, making accurate diagnosis and prompt management vital to improving prognosis.
Does MDCT-guided tPA therapy safely and effectively resolve prosthetic aortic valve thrombosis in a patient with a mechanical aortic valve?
Case Report (n=1)
No
Does MDCT-guided tPA therapy safely and effectively resolve prosthetic aortic valve thrombosis in a patient with a mechanical aortic valve?
MDCT is highly useful in diagnosing the etiology of prosthetic valve dysfunction (thrombosis vs. pannus) and guiding appropriate and safe thrombolytic therapy.
Answers are grounded in this paper and cite their sources.
MDCT may differentiate thrombus from pannus and guide safe tPA in prosthetic valve dysfunction; hypothesis-generating, leaves open prospective validation.
Key Clinical Message: In this case report, the utility of MDCT in elucidating the pathophysiology and etiology of prosthetic aortic valve dysfunction allowed us to distinguish thrombosis from pannus as an etiology of prosthetic valve dysfunction. MDCT also guided the success of therapy. Abstract: The diagnosis and management of prosthetic aortic valve thrombosis (PAVT) is challenging. The accurate diagnosis of this entity and its prompt management is vital to improving the prognosis of PAVT patients. Multidetector CT plays a central role in this effort. We present a case of PAVT in which the use of MDCT was useful in guiding management.
No takes yet. Share an insight, caveat, or question.
Dodoo et al. (2023) conducted a case report in Prosthetic aortic valve thrombosis (n=1). Tissue plasminogen activator (tPA) guided by Multidetector CT (MDCT) was evaluated on Resolution of prosthetic valve thrombus.
Synapse has enriched 10 related papers. Consider them for comparative context: